INTRODUCTION

48
Each year, about 2.2 million cases of notifiable infections are reported to the Centers for Disease 49 Control and Prevention (CDC) . These infections are caused by nearly 100 different pathogens, but the 50 majority (about 1.6 million, i.e., 60%) is due to the sexually transmitted pathogen Chlamydia trachomatis 51 (1, 2) . Still, CDC estimates that only 1 tenth of C. trachomatis-infected cases are reported because the 52 infection is mostly asymptomatic (3). Nonetheless, without proper antibiotic treatment, the infection often 53 leads to serious complications. In fact, C. trachomatis is the most common infectious cause of infertility 54 and pelvic inflammatory syndrome in women. Infection in pregnant women may result in abortion or 55 premature birth. Pathological changes in the fallopian tubes caused by C. trachomatis infection may lead 56 to ectopic pregnancy, which causes severe bleeding and likely death if the ectopically embedded embryo 57 is not detected and terminated early enough. Infants may develop C. trachomatis pneumonia following 58 acquisition of the pathogen while passing the birth canal of an infected mother. Some C. trachomatis 59 serotypes cause ocular infection, and are still the most common infectious microbes associated with 60 blindness in underdeveloped countries (4, 5).
61
Like other chlamydiae, C. trachomatis is an obligate intracellular Gram-negative bacterium that exists 62 in two cellular forms with contrasting properties (6). The small elementary body (EB) is infectious and 63 capable of extracellular survival, but incapable of proliferation. Following binding to a cellular 64 receptor(s), the EB enters a host cell membrane-derived vacuole through endocytosis (7) . Within the 65 vacuole termed inclusion, the EB differentiates into a larger cellular form termed reticulate body (RB) 66 within several h. No longer infectious, the RB divides exponentially by binary fission until around 20 h 67 when a significant portion of RBs re-differentiate back into EBs while some RBs continue proliferation 68 (8) . Progeny EBs along with residual RBs are released from infected cells following cell lysis.
69
Alternatively, whole inclusions may be released from infected cells (9).
70
The 1 million bp C. trachomatis genome encodes fewer than 1000 genes (10) . Microarray analyses 71 demonstrated that the majority of these genes are transcribed starting a few hours post-inoculation 72 throughout the remaining developmental cycle, whereas a small number of genes are transcribed 73 4 immediately following cell entry and another small set of genes are transcribed only at late stages (11, 74 12). RNA-seq detected distinct sets of gene transcripts specifically enriched in either EBs or RBs (13), 75 and purified EBs and RBs have been found to transcribe different sets of genes in axenic media (14) .
76
These findings suggest that the progression of the chlamydial developmental cycle is transcriptionally 77 regulated.
78
Transcription is initiated following binding of the RNA polymerase (RNAP) to the gene promoter 79 (15) . The bacterial RNAP holoenzyme is comprised of the catalytic core enzyme and a σ factor, which is 80 required for promoter recognition (16). Transcription of the vast majority of C. trachomatis genes 81 involves σ 66 , a homolog of σ 70 that is often referred as the housekeeping σ factor in eubacteria (16).
82
Expression of some (but not all) chlamydial late genes depends on σ 28 . Several genes possess both a σ 66 83 promoter and a σ 28 promoter (17).
84
GrgA (with the gene codes CT_504 and CTL0766 for C. trachomatis serovar D and L2, respectively) 85 is a Chlamydia-specific transcription activator (18). It was identified as a protein bound to the σ 66 -86 dependent promoter of defA, which encodes peptide deformylase, an enzyme required for bacterial 87 protein maturation and regulated protein degradation. In addition to defA, a midcycle gene, GrgA also 88 stimulates transcription from another midcycle promoter (ompA), an early promoter (rRNA P1) and a late 89 promoter (hctA), suggesting that GrgA functions as a general activator of σ 66 -dependent genes (18). In 90 this report, we demonstrate that GrgA also stimulates σ 28 -dependent gene transcription in vitro. Thus, our 91 findings suggest GrgA plays an expanded role in gene expression during the C. trachomatis 92 developmental cycle as a regulator of both σ 66 -and σ 28 -dependent transcription.
94
GrgA physically interacts with σ 28 96 To assess whether GrgA potentially regulates expression of σ 28 -dependent genes, we determined 97 whether GrgA can interact with σ 28 . We performed protein pull-down assays using differential epitope-98 tagging. The StrepTactin beads, which have affinity for the strep tag (19), precipitated NH-σ 28 (N-99 terminally poly-His-tagged C. trachomatis σ 28 ) in a manner that was dependent on the N-terminally strep-100 tagged GrgA (NS-GrgA) ( Fig. 1A) . Reciprocally, NH-GrgA was pulled down in an NS-σ 28 -dependent 101 manner (Fig. 1B) . The results establish that GrgA can directly interact with σ 28 . 102 103 GrgA has a lower affinity for σ 28 than for σ 66 104 Next, we determined the binding affinities of GrgA for both σ 28 and σ 66 . We first compared the 105 efficiencies of the σ factors in GrgA-binding by performing competitive pull-down assays. As expected, 106 NS-GrgA efficiently pulled down NH-σ 28 and CH-σ 66 in separate reactions ( Fig. S1 ). However, in the 107 presence of equal molar concentrations of NH-σ 28 and CH-σ 66 , NS-GrgA pulled down only CH-σ 66 but 108 not NH-σ 28 (Fig. S1 ), indicating that GrgA has a lower affinity for σ 28 than σ 66 .
109
We next quantitatively characterized GrgA-binding by σ 28 and σ 66 with biolayer interferometry using 110 the BLItz system, which detects light wavelength shifts at the biosensor tip with an immobilized ligand 111 following binding of an analyte in a real-time manner (20) . Whereas representative BLItz recordings 112 using NH-GrgA as a ligand, and CS-σ 66 and NS-σ 28 an analyte are shown in Fig. S2A, B ), values of 113 kinetic parameters are provided in Table 1 . The CS-σ 66 analyte yielded a statistically highly significant 114 25-fold higher ka than the NS-σ 28 analyte, suggesting that CS-σ 66 binds NH-GrgA much faster than NS-115 σ 28 . CS-σ 66 also demonstrated a 3-fold statistically significant increase in kd, suggestive of moderately 116 higher dissociation from NH-GrgA. Compared to the NH-GrgA-CS-σ 66 interaction, the NH-GrgA-NS-σ 28 117 interaction had a 32-fold higher KD, indicating that GrgA has a lower overall affinity for σ 28 than σ 66 .
118
Reciprocal BLI using CH-σ 66 and NH-σ 28 as ligands and NS-GrgA as the analyte were performed to 119 validate the difference in GrgA binding by the σ factors presented above (Fig. S2C , D and Table 1 ).
120
Consistent with the trend in ka value changes presented above, the NS-GrgA analyte also demonstrated a 121 statistically significant higher ka for CH-σ 66 than for NH-σ 28 although the difference is smaller (25-fold vs 122 3.7 fold). Interestingly, the kd values reveal that NS-GrgA also dissociates from CH-σ 66 6-fold slower than 123 from NH-σ 28 . Compared to the CH-σ 66 -NS-GrgA interaction, the NH-σ 28 -NS-GrgA interaction had a 28-124 fold higher KD, which is nearly identical to the 32-fold higher KD detected for the NH-GrgA-NS-σ 28 125 interaction vs the NH-GrgA-CS-σ 66 interaction. Thus, competitive pull-down assays and BLI establish 126 that GrgA has a lower affinity for σ 28 than for σ 66 . 
144
Our previous studies have shown that deletion of residues 114-165 disables GrgA's DNA-binding, 145 leading to loss of stimulation of transcription from σ 66 -dependent promoters, whereas removal of residues 146 1-64 disables σ 66 -binding, also causing defect in activating σ 66 -dependent transcription (18). Therefore, 147 the results in Fig. 3A suggests that 1) DNA-binding is also required for σ 28 -dependent transcription, and 148 2) the N-terminal σ 66 -interacting region may interact with σ 28 as well. Surprisingly, pull-down assays 149 demonstrated that GrgA114-165 is completely defective in σ 28 -binding, whereas GrgA1-64 appeared 150 to have only a slightly decreased σ 28 -binding activity ( Fig. 3B ).
151
We performed a series of deletions within the 114-165 region to define the elements required for 152 interacting with either DNA or σ 28 . Since residues 114-138 are predicted to have coiled and stranded 153 structures, whereas residues 139-158 are rich in positively charged lysine and aspartate, and are predicted 154 to form a helix ( Fig. S4 ), we expected GrgA114-137 but not GrgA138-165 to retain DNA-binding 155 activity. EMSA confirmed this prediction ( Fig. 3C ). Interestingly, GrgA114-137 but not GrgA138-165 156 also retained σ 28 -binding activity as well ( Fig. 3D ). Not surprisingly, GrgA114-137 but not GrgA138-157 165 retained the capacity to activate σ 28 -dependent transcription (Fig. 3E ). Additional and extensive 158 deletion mutagenesis and functional analyses for the region of residues 138-165 failed to 1) separate 159 residues required for σ 28 -binding from residues required for DNA-binding ( Fig. S5 & S6 ), and 2) define a 160 smaller region fully required for binding either σ 28 or DNA ( Fig. S5 & S6) . These studies suggest that σ 28 161 and DNA bind to the same region in GrgA, and further confirm that σ 28 -and DNA-binding are required 162 for activation of σ 28 -dependent transcription (Fig. S7 ).
164
Residues 1-64 in GrgA contribute to σ 28 -binding 165 Transcription assays showed a 50% loss of activity in activating σ 28 -dependent transcription in the 166 GrgAΔ1-64 mutant (Fig. 3A) . We used the BLItz system (20) to confirm decreased σ 28 -binding activity in 167 mutants as ligands and NS-σ 28 as analyte are shown in Fig. S8A -D, and kinetic parameters are provided in 169 Table 2 . Compared to the full length NH-GrgA, NS-σ 28 revealed a moderately slowed association with 170 and a moderately accelerated dissociation from the NH-GrgAΔ1-64, as indicated by a nearly 3-fold 171 decrease in the ka and a 2-fold increase in the kd (Table 2 ). These changes resulted in a highly significant 172 4.8-fold increase in the KD value. On the other hand, NH-GrgAΔ114-137, which retains the activity to 173 activate σ 28 -dependent transcription (Fig. 3E ), demonstrated no changes in kinetic parameters for 174 interaction with NS-σ 28 ( Table 2) . In contrast to NH-GrgAΔ114-137, NH-GrgAΔ138-165 immediately 175 and completely dissociated from NS-σ 28 upon wash ( Fig. S8D ), leading to a 1.5 X 10 6 times higher kd and 176 a 3.1 X 10 6 times higher KD (Table 2) , which are fully consistent with pull-down data ( Fig. 3D ).
177
Furthermore, unlike NS-σ 28 , which retained a low affinity for NH-GrgAΔ1-64 (relative to full length NH-178 GrgA), CS-σ 66 quickly and completely dissociated from NH-GrgAΔ1-64 upon wash ( Fig. S8E ), which is 179 consistent with pull-down data previously reported (18). Taken together, the BLItz data in Fig. S8 and 180 Table 2 indicate that the decreased affinity with NS-σ 28 in NH-GrgAΔ1-64 is responsible for the partial 181 loss of activity in activating σ 28 -dependent transcription ( Fig 3A) .
183
The N-terminus of σ 28 is most critical for binding GrgA
184
We constructed NH-σ 28 variants with deletion of the N-terminal leader sequence, σ factor region 2, 3 185 or 4 (unlike the housekeeping σ factor, σ 28 does not contain region 1) ( Fig. 4A ). All deletion mutants (i.e.,
186
NH-σ 28 ΔNL, NH-σ 28 ΔR2, NH-σ 28 ΔR3 and NH-σ 28 ΔR4) were expressed in E. coli (Fig. 4B ). Noticeably, 187 in pull-down assays, NS-GrgA completely failed to pull down the NH-σ 28 ΔNL and NH-σ 28 ΔR2 mutants, 188 and pulled down only small amounts of NH-σ 28 ΔR3 and NH-σ 28 ΔR4, compared to full length NH-σ 28 189 ( Fig. 4C ).
190
In BLItz assays, the rate of association with NH-GrgA varied greatly among the σ 28 deletion mutants.
191
Whereas NH-σ 28 ΔNL had essentially the same ka as full length NH-σ 28 , NH-σ 28 ΔR2 displayed a 192 significant 2-fold reduction in ka. In contrast, NH-σ 28 ΔR3 and NH-σ 28 ΔR4 showed a 3.5-fold increase and 193 the kd (Table 3) . Consequently, NH-σ 28 ΔNL and NH-σ 28 ΔR2 had 345-and 177-fold higher KD value, 195 respectively, whereas NH-σ 28 ΔR3 and NH-σ 28 ΔR4 both demonstrated 7 fold higher KD values (Table 3) .
196
Representative graphs of BLItz recordings are shown in Fig. S9 . Taken together, both the pull-down (Fig.   197 4) and BLI data (Table 3) indicate that the N-terminus of σ 28 (i.e., NL and R2) interacts with GrgA while 198 R3 and R4 stabilize the GrgA-σ 28 binding.
200
Although GrgA was first identified as a transcription activator for σ 66 -dependent genes (18), the 202 present study has demonstrated that GrgA potentially stimulates expression of σ 28 -dependent genes.
203
Transcription of chlamydial genes is temporally controlled during the developmental cycle (11, 12, 17, 204 22, 23) . Whereas σ 66 is involved in transcription of most C. trachomatis genes, some late promoters are 205 recognized by σ 28 (17). Microarray studies have shown that synthesis of the σ 28 mRNA temporally falls 206 behind the σ 66 mRNA (11, 12) . Thus, it would be safe to assume that GrgA primarily activates σ 66 -207 dependent genes in earlier developmental stages.
208
Whether or not GrgA also regulates expression of σ 28 -dependent genes during later developmental 209 stages likely depends on the expression levels of GrgA, σ 28 and σ 66 . If GrgA is limited, σ 28 would have to 210 be present at significantly higher concentrations than σ 66 to effectively compete for GrgA. However, 211 quantitative whole proteomic mass spectrometry analyses detected higher levels of GrgA relative to σ 66 in 212 both EBs and RBs purified from the midcycle (24) whereas σ 28 was undetected in either cellular form (24, 213 25). Thus, GrgA could potentially stimulate transcription from σ 28 -dependent promoters in addition to σ 66 -214 dependent promoters regardless the molar ratio of the two σ factors. Accurate quantification of GrgA and 215 σ factors in different stages of the developmental cycle will help elucidate the role of GrgA in the 216 expression of σ 66 -and/or σ 28 -dependent genes in different developmental stages.
217
We used both pull-down assays and BLI to analyze the interaction of GrgA with σ 28 and σ 66 . Clearly, 218 owing to its quantitative nature, BLI offers higher sensitivities than protein pull-down assays in studying 219 protein-protein interaction. This led to the confirmation that decreased affinity for σ 28 in GrgAΔ1-64, 220 which was ambiguous in pull-down assays, is the most probable cause for a 50% loss of activity in 221 activating σ 28 -dependent transcription.
222
We have defined a middle region in GrgA (residues 138-165) as a σ 28 -and DNA-binding domain 223 ( Fig. 3) . Extensive deletion mutagenesis in this region failed to divide it into subdomains that bind either 224 σ 28 or DNA but not both (Figs. S5 & S6) . We speculate that multiple positively-charged residues (K138, 225 K139, R142, R143, K144, K147, K150, K152, K154-156, R159-161 and/or K164) interact with 226 11 negatively charged DNA whereas multiple negatively-charged residues E141, E145, E149, D153 and/or 227 E165) interact with σ 28 .
228
GrgA has demonstrated similar but not identical properties in activating σ 66 -and σ 28 -dependent 229 transcription. Apparently, sequence-nonspecific DNA-binding is required for activating both σ 66 -230 dependent transcription (18) and σ 28 -dependent transcription (Fig. 3A, E & Fig. S7 ). However, the N-231 terminal region (residues 1-64) of GrgA has a stronger role in σ 66 -dependent transcription (18) than in σ 28 -232 dependent transcription (Fig. 3A) because this region is absolutely required for GrgA to interact with σ 66 233 (18), but plays only a supportive role in binding σ 28 , which was clearly evident only with BLI ( Table 2) 234 but appeared uncertain with pull-down assays (Fig. 3B ).
235
Whereas the major GrgA structural determinants for binding σ 28 and σ 66 differ, there is similarity 236 between the GrgA-binding regions in the two σ factors. The GrgA-binding sequence in σ 66 is the last 237 portion of the non-conserved region immediately upstream of the conserved region 2, whereas the GrgA-238 binding sequence in σ 28 also involves the N-terminal non-conserved leader sequence (and the immediately 239 downstream region 2). To the best of our knowledge, GrgA is the only transcription factor that targets 240 non-conserved regions of σ factors (16).
241
In summary, we have demonstrated that the Chlamydia-specific GrgA can activate both σ 66 -242 dependent transcription and σ 28 -dependent transcription in vitro. Current knowledge suggests that GrgA 243 primarily activates σ 66 -dependent genes during earlier developmental stages. However, whether or not 244 GrgA also regulates expression of σ 28 -dependent genes during later developmental stages likely depends 245 on the expression levels of GrgA, σ 28 and σ 66 because GrgA has a lower affinity for σ 28 than σ 66 . To date,
246
GrgA remains the only transcription factor that targets non-conserved regions of σ factors (16). Table   269 S1. Sequences of primers used for constructing expression plasmids (GrgA deletion mutants, NS-σ 28 ) and (Table S1) 
319
GrgA-DNA interaction was determined by EMSA as described previously (18). 32 P-labeled DNA 320 fragment containing the C. trachomatis defA promoter (26) was amplified using a 32 P-labeled 5' primer 321 and an unlabeled 3' primer (Table S2) (1.9 ± 1.3) X 10 6 100 (9.3 ± 5.2) X 10 -3 100 (6.9 ± 5.9) X 10 -9 100 NH-GrgA NS-σ 28 8 (1.5 ± 1.7) X 10 4 4.0 (2.8 ± 0.8) X 10 -3 30 (2.2 ± 1.1) X 10 -7 3188 p = 0.001 p = 0.001 p < 0.001 CH-σ 66 NS-GrgA 4 (7.7 ± 1.3) X 10 5 100 (8.9 ± 0.6) X 10 -3 100 (1.2 ± 0.1) X 10 -8 100 NH-σ 28 NS-GrgA 6 (2.1 ± 0.9) X 10 5 27 (5.6 ± 1.2) X 10 -2 629 (3.4 ± 2.0) X 10 -7 2833 p < 0.001 p < 0.001 p = 0.013
435
BLItz assays were performed with His biosensors using indicated ligand and analyte pairs. Representative 436 graphs of recordings are shown in Fig. S2 1 ± 0. 2) X 10 -6 479 p = 0.037 p = 0.009 p < 0.001
NH-GrgAΔ114-137 4 (1.5 ± 0.4) x 10 4 98 (3.5 ± 0.5) x 10 -3 124 (2.5 ± 0.3) x 10 -7 112 p = 0.947 p = 0.128 p = 0.658 NH-GrgAΔ138-165 2 (5.6. ± 0.1) x 10 3 37 (4.1 ± 0.3) x 10 2 1.5 X 10 8 (6.9 ± 4.5) x 10 -2 3.1 X 10 8 p = 0.125 p = 0.002 p < 0.001 446 Indicated His-tagged proteins were immobilized on His biosensors as ligands for the NS-σ 28 analyte in 447 BLItz assays. Representative graphs of BLItz recordings are shown in Fig. S8 . See Table 1 . 1 µM full length GrgA (FL) or indicated deletion mutant was used per assay. p1 is the p value between basal transcription activity (without GrgA) and activity with GrgA (FL or mutant); p2 is the p value between FL and the deletion mutant (paired t tests of three independent experiments); na, not applicable. (B) Pull-down of NH-GrgA full length (FL) and Δ1-64 but not Δ 114-165 by StrepTactin bead-immobilized NS-σ 28 . GrgA and deletion mutants were detected by western blotting using a mouse anti-GrgA antibody because the anti-His used in (A & B) does not recognize 1-64 (18). (C) Δ138-165 but not Δ114-137 is defective in DNA-binding like Δ114-165. Electrophoresis mobility shift assays (EMSA) were performed using a radiolabeled DNA fragment carrying sequences extending from position -144 to +52 of the defA gene (18) in the presence of the indicated concentrations of wild-type GrgA or the indicated GrgA mutant. (D) Δ138-165 but not Δ114-137 is defective in σ 28 -binding. Protein pull-down and detection were performed as described in B, with the exception of detection via anti-His. (E) 138-165 but not NH-GrgAΔ114-137 is fully defective in activating transcription from the hctB promoter. See Fig. 1D legend for experimental and statistical information. 
